COVID-19 treatment: 58 Ayurveda interventions registered for clinical trials till 25 June
As many as 58 new COVID-19 trials involving Ayurveda intervention were registered from 1 March to 25 June in the Clinical Trial Registry of India, highlighting the emerging nationwide trend of evidence-based studies in Ayush disciplines. Of the 58 registered trials, 52 (89.66 per cent) are interventional trials and six (10.34 percent) are observational trials. News reports in August this year had revealed that out of the 203 trials registered in the CTRI, 61.5 percent were from Ayush disciplines.
A recent study published in the ‘Journal of Research in Ayurvedic Sciences’ titled ‘Ayurveda Research Studies on COVID-19 Registered in CTRI: A Critical Appraisal’ throws more light on this growing “research culture” in Ayush disciplines. Of the total trials registered, approximately 70 per cent were sponsored by the government and various Ayurveda stakeholders associated with the Ministry of AYUSH.
Further, in these challenging times, they will provide information for the global scientific community to know about the outcomes of Ayurveda clinical trials being conducted on COVID-19 in India. The majority of the trials included adult participants of both genders as the target population. The instant paper which is authored by researchers of the Central Council for Research in Ayurvedic Sciences provides detailed information about Ayurveda-based COVID-19 clinical trials with respect to administrative information on trial registry number and sponsorship, descriptive information on study type and length of study and study design.